Immunovant, Inc.
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fra…
Biotechnology
US, New York [HQ]
IMVT/Financials
Segments · Problems · Premarket · Compliance
Segment Analysis
Segments · Problems · Premarket · ComplianceSegment Analysis
Revenue · By Business Segment
These hierarchically ordered segment trees are sourced from the most recent 10-K filings, directly from the SEC.
Not available for IMVT
Revenue · By Area
This map and table comes from the most recent 10-K filings, directly from the SEC.
Not available for IMVT